药明康德(02359.HK)获FMR LLC增持12.29万股_老虎社区_美港股上老虎

药明康德(02359.HK)获FMR LLC增持12.29万股

格隆汇2021-08-04

格隆汇APP获悉，根据联交所最新权益披露资料显示，2021年7月29日，药明康德(02359.HK)获FMR LLC在场内以每股均价176.9961港元增持12.29万股，涉资约2174.68万港元。

增持后，FMR LLC最新持股数目为19,467,037股，持股比例由4.98%上升至5.01%。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

老干
·2021-08-04
😊[微笑]
回复
1
举报

热议股票

7x24

全部

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2156393178?lang=zh_CN&edition=full","thumbnail":"https://static.tigerbbs.com/20e6fa66017937fe813c3ab4efba6858","is_english":false,"pubTime":"2021-08-04 06:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2156393178","market":"hk","top_or_hot":-1,"title":"药明康德(02359.HK)获FMR LLC增持12.29万股","media":"格隆汇","content":"<html><body><p>格隆汇APP获悉，根据联交所最新权益披露资料显示，2021年7月29日，<a href=\"https://laohu8.com/S/WX\">药明康德</a>(02359.HK)获FMR LLC在场内以每股均价176.9961港元增持12.29万股，涉资约2174.68万港元。</p><p>增持后，FMR LLC最新持股数目为19,467,037股，持股比例由4.98%上升至5.01%。</p><p><img src=\"https://img3.gelonghui.com/cd536-4d86b85e-6086-45f3-9096-1e17c4f38f0e.png\"/></p></body></html>","source":"stock_gelonghui","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>药明康德(02359.HK)获FMR LLC增持12.29万股</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n药明康德(02359.HK)获FMR LLC增持12.29万股\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-04 06:48 北京时间&nbsp;&nbsp;&nbsp;<a href=https://www.gelonghui.com/news/detail.html?id=593994><strong>格隆汇</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>格隆汇APP获悉，根据联交所最新权益披露资料显示，2021年7月29日，药明康德(02359.HK)获FMR LLC在场内以每股均价176.9961港元增持12.29万股，涉资约2174.68万港元。增持后，FMR LLC最新持股数目为19,467,037股，持股比例由4.98%上升至5.01%。</p>\n\n<a href=\"https://www.gelonghui.com/news/detail.html?id=593994\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"603259","symbol_name":"药明康德","start_time":0,"source_url":"https://www.gelonghui.com/news/detail.html?id=593994","article_id":"2156393178","we_media_id":null,"thumbnails":["https://static.tigerbbs.com/20e6fa66017937fe813c3ab4efba6858"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2156393178","pubTimestamp":1628030908,"columns":[],"sourceInfo":{"source_id":"stock_gelonghui","name":"格隆汇"},"weMediaInfo":null,"summary":"格隆汇APP获悉，根据联交所最新权益披露资料显示，2021年7月29日，药明康德(02359.HK)获FMR LLC在场内以每股均价176.9961港元增持12.29万股，涉资约2174.68万港元。增持后，FMR LLC最新持股数目为19,467,037股，持股比例由4.98%上升至5.01%。","collect":0,"end_time":0,"defaultTopTitle":"gelonghui.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"603259":"药明康德","02359":"药明康德"},"translate_title":"Wuxi Apptec Co.,Ltd. (02359. HK) received an increase of 122,900 shares from FMR LLC","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"603259":1,"02359":1,"VIRI":1,"WX":1},"content_text":"格隆汇APP获悉，根据联交所最新权益披露资料显示，2021年7月29日，药明康德(02359.HK)获FMR LLC在场内以每股均价176.9961港元增持12.29万股，涉资约2174.68万港元。增持后，FMR LLC最新持股数目为19,467,037股，持股比例由4.98%上升至5.01%。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"},"commentList":[{"id":890096343,"gmtCreate":1628064775382,"gmtModify":1628064775382,"author":{"id":"3506167818151781","authorId":"3506167818151781","name":"老干","avatar":"https://static.tigerbbs.com/fcacd1d23dd6920d6800318c697b23a6","vip":1,"crmLevel":1,"crmLevelSwitch":1,"idStr":"3506167818151781","authorIdStr":"3506167818151781"},"htmlText":"😊[微笑]&nbsp;","listText":"😊[微笑]&nbsp;","text":"😊[微笑]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/890096343","repostId":2156393178,"repostType":2,"repost":{"id":"2156393178","kind":"news","pubTimestamp":1628030908,"share":"https://www.laohu8.com/m/news/2156393178?lang=&edition=full","pubTime":"2021-08-04 06:48","market":"hk","language":"zh","title":"药明康德(02359.HK)获FMR LLC增持12.29万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2156393178","media":"格隆汇","summary":"格隆汇APP获悉，根据联交所最新权益披露资料显示，2021年7月29日，药明康德(02359.HK)获FMR LLC在场内以每股均价176.9961港元增持12.29万股，涉资约2174.68万港元。增持后，FMR LLC最新持股数目为19,467,037股，持股比例由4.98%上升至5.01%。","content":"<html><body><p>格隆汇APP获悉，根据联交所最新权益披露资料显示，2021年7月29日，<a href=\"https://laohu8.com/S/WX\">药明康德</a>(02359.HK)获FMR LLC在场内以每股均价176.9961港元增持12.29万股，涉资约2174.68万港元。</p><p>增持后，FMR LLC最新持股数目为19,467,037股，持股比例由4.98%上升至5.01%。</p><p><img src=\"https://img3.gelonghui.com/cd536-4d86b85e-6086-45f3-9096-1e17c4f38f0e.png\"/></p></body></html>","source":"stock_gelonghui","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>药明康德(02359.HK)获FMR LLC增持12.29万股</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n药明康德(02359.HK)获FMR LLC增持12.29万股\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-04 06:48 北京时间&nbsp;&nbsp;&nbsp;<a href=https://www.gelonghui.com/news/detail.html?id=593994><strong>格隆汇</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>格隆汇APP获悉，根据联交所最新权益披露资料显示，2021年7月29日，药明康德(02359.HK)获FMR LLC在场内以每股均价176.9961港元增持12.29万股，涉资约2174.68万港元。增持后，FMR LLC最新持股数目为19,467,037股，持股比例由4.98%上升至5.01%。</p>\n\n<a href=\"https://www.gelonghui.com/news/detail.html?id=593994\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/20e6fa66017937fe813c3ab4efba6858","relate_stocks":{"603259":"药明康德","02359":"药明康德"},"source_url":"https://www.gelonghui.com/news/detail.html?id=593994","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2156393178","content_text":"格隆汇APP获悉，根据联交所最新权益披露资料显示，2021年7月29日，药明康德(02359.HK)获FMR LLC在场内以每股均价176.9961港元增持12.29万股，涉资约2174.68万港元。增持后，FMR LLC最新持股数目为19,467,037股，持股比例由4.98%上升至5.01%。","news_type":1,"symbols_score_info":{"603259":1,"02359":1,"VIRI":1,"WX":1}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":0,"commentSize":1,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}